Paraneoplastic Syndrome: What should Pulmonologists know?
DOI:
https://doi.org/10.17140/PRRMOJ-4-e009Abstract
Pulmonologists often encounter patients with oncologic emergencies such as metabolic syndrome (tumor lysis syndrome), hypercalcemia, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), hematologic (febrile neutropenia and hyperviscosity syndrome) and structural disorders (superior vena cava syndrome, spinal cord compression syndrome, malignant pericardial effusion, and malignant airway obstruction), along with drug-related adverse events in already-known malignancies including liver5 or pulmonary toxicity and renal disease.
References
Honda K, Saraya T, Tamura M, Yokoyama T, Fujiwara M, Goto H. Tumor lysis syndrome and acquired ichthyosis occurring after chemotherapy for lung adenocarcinoma. J Clin Oncol. 2011; 29(35): e859-e860. doi: 10.1200/jco.2011.36.8175
Saraya T, Shimura C, Mikura S, et al. Huge mediastinal mass with SVC syndrome accompanying numerous chest wall collateral vessels. Intern Med. 2008; 47(19): 1719-1722. doi: 10.2169/internalmedicine.47.1076
Saraya T, Takata S, Fujiwara M. The role of vital signs in predicting cardiac tamponade in asymptomatic patients with malignan-cy-associated pericardial effusion. Pulm Res Respir Med Open J. 2016; SE(1): S3-S7. doi: 10.17140/PRRMOJ-SE-1-102
Nakajima A, Saraya T, Takata S, et al. The saw-tooth sign as a clinical clue for intrathoracic central airway obstruction. BMC Res Notes. 2012; 5: 388. doi: 10.1186/1756-0500-5-388
Hirukawa I, Saraya T, Wada S, Takizawa H. Marked enlargement of liver over a short period of time illustration. Pulm Res Respir Med Open J. 2016; 3(1): 1. doi: 10.17140/PRRMOJ-3-123
Tamura M, Saraya T, Fujiwara M, et al. High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases. Oncologist. 2013; 18(4): 454-459. doi: 10.1634/theoncologist.2012-0248
Koide T, Saraya T, Nakamoto K, et al. A case of imatinib mesylate-induced pneumonitis based on the detection of epithelioid granulomas by video-assisted thoracoscopic surgery biopsy in a patient with chronic myeloid leukemia. Nihon Kokyuki Gakkai Zasshi. 2011; 49(6): 465-471.
Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: A review. Am J Med Sci. 2007; 334(2): 115-124. doi: 10.1097/MAJ.0b013e31812dfe1e
Toriumi S, Sara-ya T, Tsujimoto N. Renal salt wasting syndrome due to carboplatin in a patient with lung cancer. Pulm Res Respir Med Open J. 2014; 1(1): 9-12. doi: 10.17140/PRRMOJ-1-102
Graus F, Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol. 2012; 25(6): 795-801. doi: 10.1186/1750-1172- 2-22
Higaki M, Kurai D, Ito A, Saraya T. Evidence for hypohydrosis as clinical clue to diagnosis of Horner’s syndrome. BMJ Case Rep. 2013; 2013. doi: 10.1136/bcr-2013-009732
Nishizawa T, Saraya T, Kurai D, et al. Good syndrome occurred in a patient a prolonged time after thymectomy: A case report and literature review of cases in Japan. Journal of General and Family Medicine. 2016; 17(3): 238-243. doi: 10.14442/jgfm.17.3_238
Sakamori Y, Kim YH, Okuda C, et al. Two cases of cancer-associated retinopathy combined with small-cell lung cancer. Jpn J Clin Oncol. 2011; 41(5): 669-673. doi: 10.1093/jjco/hyr025
Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009; 70(1): 39-58. doi: 10.1016/j.critrevonc.2008.08.003
Owen CE. Cutaneous manifestations of lung cancer. Semin Oncol. 2016; 43(3): 366-369. doi: 10.1053/j.seminoncol.2016.02.025
Higaki M, Ishida M, Nakamoto Y, Saraya T. Horner’s syndrome with a sensation of warmth due to hypohidrosis. Intern Med. 2013; 52(15): 1757-1758. doi: 10.2169/internalmedicine.52.0660
Kanaji N, Watanabe N, Kita N, et al. Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol. 2014; 5(3): 197-223. doi: 10.5306/wjco.v5.i3.197
Saraya T, Fujiwara M, Shimura C, Goto H. Not paraneoplastic pemphigus but pemphigus vulgaris in a patient with thymoma. BMJ Case Rep. 2015; 2015. doi: 10.1136/bcr-2015-210433
Spiro SG, Gould MK, Colice GL, American College of Chest P. Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd ed). Chest. 2007; 132(Suppl 3): 149S-160S. doi: 10.1378/chest.07-1358
Lancaster E, Dalmau J. Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012; 8(7): 380390. doi: 10.1038/nrneurol.2012.99
Ost DE, Jim Yeung SC, Tanoue LT, Gould MK. Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(Suppl 5): e121S-e41S. doi: 10.1378/chest.12-2352
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Pulmonary Research and Respiratory Medicine (PRRM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
